Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma

BACKGROUND: Downregulation of Aldolase B (ALDOB) has been reported in hepatocellular carcinoma. However, its clinical significance and its role in pathogenesis of HCC remain largely unknown. METHODS: We analyzed the expression of ALDOB and its clinical features in a large cohort of 313 HCC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Qi-fei, Yuan, Sheng-xian, Yang, Fu, Yang, Sen, Yang, Yuan, Yuan, Ji-hang, Wang, Zhen-guang, Xu, Qing-guo, Lin, Kong-ying, Cai, Jie, Yu, Jian, Huang, Wei-long, Teng, Xiao-lei, Zhou, Chuan-chuan, Wang, Fang, Sun, Shu-han, Zhou, Wei-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574028/
https://www.ncbi.nlm.nih.gov/pubmed/26376879
http://dx.doi.org/10.1186/s12943-015-0437-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574028/
https://www.ncbi.nlm.nih.gov/pubmed/26376879
http://dx.doi.org/10.1186/s12943-015-0437-7

Ejemplares similares